ESRRA and type 2 diabetes mellitus: Orphan nuclear receptor oestrogen-related receptor α (ERRα, NR3B1) is a key transcriptional regulator of mitochondrial function, redox homeostasis and energy metabolism12–14, thus being an attractive therapeutic target for the treatment of metabolic disorders and diseases including type 2 diabetes, obesity and cancer15–17.